anti-gluten antibodies (Circle33)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-gluten antibodies (Circle33)
Drug Alias Nameanti-gluten antibodies (Avaxia Biologics)AVX-2005AVX-176
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionGliadin inhibitorsImmunomodulators
TargetsGliadin
Therapy Area/IndicationsCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvaxia Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvaxia Biologics IncCircle33 LLC
Active IndicationsN/A
Inactive IndicationsCeliac Disease

Other Information

ATC CodeN/A
Related LinksN/A